NHRA updated “Medicine Submission, Renewal & Variations Guidelines”
NHRA has updated three key pharmaceutical regulatory guidelines in Bahrain as part
Regulinked
- May 16, 2026
- Guideline
- No Comments
Tag: NHRA
NHRA – “Alternative and Complementary Medicines Guideline” (V 1.2)
NHRA issues updated “Alternative and Complementary Medicines Guideline” (V 1.2) 🔍 What’s
- November 22, 2025
- Guideline
- No Comments
NHRA – issues updated “Medicine Renewal Guideline” V 2.1 & “Medicine Variations Guideline” V 3.1
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
- November 13, 2025
- Guideline
- No Comments
NHRA – updated “International Manufacturing Site Licensing Procedure”
NHRA issues updated “International Manufacturing Site Licensing Procedure” Guideline (Version 1.6)
- November 10, 2025
- Guideline
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.
Contact
- +971555473407
- BD@regulinked.com
- consultation@regulinked.com